If you're interested in

This monthly four-page newsletter summarizes the changes in the drug development plans
of  U.S. and Canadian pharmaceutical companies.  Each issue alerts you to more than 120 products that are moving through the pipeline.  Learn what the competition is up to, how far along they are in developing drugs for certain indications and what their future plans are -- all arranged in convenient table format.

If you're interested in Reports which contain pipeline information in specific areas;
See our Emerging Pharmaceutical Series.